MARKET

STAA

STAA

STAAR Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

95.10
-8.65
-8.34%
After Hours: 95.10 0 0.00% 19:57 03/03 EST
OPEN
102.31
PREV CLOSE
103.75
HIGH
103.20
LOW
95.05
VOLUME
642.68K
TURNOVER
--
52 WEEK HIGH
128.23
52 WEEK LOW
23.20
MARKET CAP
4.43B
P/E (TTM)
793.82
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Posterior Chamber Lens Market Trends By 2021 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By Market Growth Reports
The Express Wire · 1d ago
Cataract Surgery Devices Market 2021 : Top countries Data, Market Size, In-Depth Analysis with Booming Trends and Segmentation Forecast to 2026
Mar 01, 2021 (The Expresswire) -- Global “Cataract Surgery Devices Market" 2021-2026 Research Report provides key analysis on the market status of the...
The Express Wire · 2d ago
Ophthalmology Medical Device Market Break Down By Leading Companies, Countries, Applications, Opportunities And Forecast 2022-2031
Feb 26, 2021 (WiredRelease via Comtex) -- A recent systematic review report on “Ophthalmology Medical Device Market Outlook and Opportunities in Grooming...
marketresearch.biz · 5d ago
Current research: Ophthalmic Devices Market key players insight & growth driver analysis 2021
The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.
Market Insight Reports · 6d ago
Ophthalmology Surgery Devices Market Size 2021 By Share, Industry Statistics, Trends Evaluation, Business Challenges and Investment Opportunities Analysis till 2026
Feb 25, 2021 (The Expresswire) -- The Ophthalmology Surgery Devices industry has undergone many changes in recent years and expects numerous variations in...
The Express Wire · 02/25 06:33
DJ STAAR Surgical Company CEO Caren Mason on Q4 2020 Results -- Earnings Call Transcript >STAA
Dow Jones · 02/25 02:36
BTIG Reaffirms Their Hold Rating on Staar Surgical Company (STAA)
BTIG analyst Ryan Zimmerman maintained a Hold rating on Staar Surgical Company (STAA) yesterday. The company's shares closed last Wednesday at $114.86,
SmarterAnalyst · 02/25 01:25
8-K: STAAR SURGICAL CO
(EDGAR Online via COMTEX) -- false 0000718937 0000718937 2021-02-24 2021-02-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 02/24 22:51
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of STAA. Analyze the recent business situations of STAAR Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average STAA stock price target is 119.00 with a high estimate of 135.00 and a low estimate of 88.00.
EPS
Institutional Holdings
Institutions: 316
Institutional Holdings: 48.87M
% Owned: 104.95%
Shares Outstanding: 46.56M
TypeInstitutionsShares
Increased
58
2.07M
New
51
94.88K
Decreased
73
1.71M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.37%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Independent Director
Louis Silverman
President/Chief Executive Officer/Director
Caren Mason
Chief Financial Officer
Patrick Williams
Senior Vice President
Hans-Martin Blickensdoerfer
Senior Vice President
James Francese
Vice President - Finance
Surindra Mann
Senior Vice President
Graydon Hansen
Chief Technology Officer
Keith Holliday
Vice President
Jon Hayashida
Other
Scott Barnes
Secretary
Samuel Gesten
Director
Thomas Frinzi
Director
Gilbert Kliman
Director
Elizabeth Yeu
Director
K. Peony Yu
Independent Director
Stephen Farrell
Independent Director
John Moore
  • Dividends
  • Splits
  • Insider Activity
No Data
About STAA
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29, 2017, the Company sold its products in over 75 countries, with distribution in the United States, Canada, Japan and Spain.

Webull offers kinds of STAAR Surgical Company stock information, including NASDAQ:STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.